Advertisement

Radiation Therapy for Lung Cancer in Elderly

  • Branislav Jeremić
  • Željko Dobrić
Chapter
Part of the Medical Radiology book series (MEDRAD)

Abstract

Western world is rapidly aging, yet the exact threshold age for differentiating elderly versus non-elderly is not widely adopted. Elderly are also underrepresented in clinical trials and level of evidence of preferred treatment in both non-small-cell and small-cell lung cancer is basically lacking. From the existing evidence, however, it seems that radiation therapy is safe and effective treatment modality in patients with early stage non-small-cell lung cancer. It is so also in locally advanced non-small-cell lung cancer when combined with radiochemotherapy, although caution should be exercised when one attempts to combine high-dose radiation therapy with high-dose chemotherapy. Similarly, palliative radiation therapy is effective in elderly with non-small-cell lung cancer unsuitable for radical approach, with or without additional chemotherapy. Finally, in small-cell lung cancer, again, radiation therapy can successfully be employed either alone or, most frequently, with chemotherapy in treatment of both limited and extensive-disease small-cell lung cancer. While largely unsubstantiated fear has governed our approaches in elderly with lung cancer in recent decades, novel radiation therapy technologies and novel drugs should provide suitable framework for embarking on more clinical trials in elderly.

Keywords

Lung Cancer Propensity Score Median Survival Time Intensity Modulate Radiation Therapy Radiation Therapy Oncology Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Ahmad E, Sandhu AP, Fuster MM, Messer K, Pu M, Nobiensky P, Bazhenova L, Seagren S (2010) Hypofractionated radiotherapy as definitive treatment of Stage I non-small-cell lung cancer in older patients. Am J Clin Oncol. 17 Jun 2010. [Epub ahead of print]Google Scholar
  2. Albain KS, Crowley JJ, LeBlanc M, Livingston RB (1990) Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base. J Clin Oncol 8:1563–1574PubMedGoogle Scholar
  3. Aristizabal SA, Caldwell WL (1976) Radical irradiation with the split-course technique in carcinoma of the lung. Cancer 37:2630–2635PubMedCrossRefGoogle Scholar
  4. Aristizabal SA, Meyerson M, Caldwell WL, Mayer EG (1976) Age as a prognostic indicator in carcinoma of the lung. Radiology 121:721–723PubMedGoogle Scholar
  5. Atagi S, Kawahara M, Ogawara M, Matsui K, Masuda N, Kudoh S, Negoro S, Furuse K (2000) Phase II trial of daily low-dose carboplatin and thoracic radiotherapy in elderly patients with locally advanced non-small-cell lung cancer. Jpn J Clin Oncol 30:59–64PubMedCrossRefGoogle Scholar
  6. Atagi S, Kawahara M, Tamura T, Noda K, Watanabe K, Yokoyama A, Sugiura T, Senba H, Ishikura S, Ikeda H, Ishizuka N, Saijo N, Japan Clinical Oncology Group (JCOG9812) (2005) Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small-cell lung cancer: a phase III trial of the Japan Clinical Oncology Group (JCOG9812). Jpn J Clin Oncol 35:195–201PubMedCrossRefGoogle Scholar
  7. Auperin A, Arriagada R, Pignon JP, Gregor A, Stephens RJ, Kristjansen PE, Johnson BE, Ueoka H, Wagner H, Aisner J (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic cranial irradiation overview collaborative group. N Engl J Med 341:476–484PubMedCrossRefGoogle Scholar
  8. Bach PB, Cramer LD, Warren JL, Begg CB (1999) Racial differences in the treatment of early-stage lung cancer. N Engl J Med 341:1198–1205PubMedCrossRefGoogle Scholar
  9. Balducci L, Extermann M (2000a) Cancer and aging. An evolving panorama. Hematol Oncol Clin North Am 14:1–16PubMedCrossRefGoogle Scholar
  10. Balducci L, Extermann M (2000b) Management of cancer in the older person: a practical approach. Oncologist 5:224–237PubMedCrossRefGoogle Scholar
  11. Bernabei R, Venturiero R, Tarsitani P, Gambassi G (2000) The comprehensive geriatric assessment: When, where, how. Crit Rev Oncol Hematol 33:45–56PubMedCrossRefGoogle Scholar
  12. Bonner JA, Sloan JA, Shanahan TG, Brooks BJ, Marks RS, Krook JE, Gerstner JB, Maksymiuk A, Levitt R, Mailliard JA, Tazelaar HD, Hillman S, Jett JR (1999) Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma. J Clin Oncol 17:2681–2691PubMedGoogle Scholar
  13. Clamon G, Herndon J, Cooper R, Chang AY, Rosenman J, Green MR (1999) Radiosensitization with carboplatin for patients with unresectable Stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group. J Clin Oncol 17:4–11PubMedGoogle Scholar
  14. Coate LE, Massey C, Hope A, Sacher A, Barrett K, Pierre A, Leighl N, Brade A, de Perrot M, Waddell T, Liu G, Feld R, Burkes R, Cho BC, Darling G, Sun A, Keshavjee S, Bezjak A, Shepherd FA (2011) Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for Stage III non-small-cell lung cancer. J Thorac Oncol 6:537–544PubMedCrossRefGoogle Scholar
  15. Coy P, Kennelly GM (1980) The role of curative radiotherapy in the treatment of lung cancer. Cancer 45:698–702PubMedCrossRefGoogle Scholar
  16. Dajczman E, Fu LY, Small D, Wolkove N, Kreisman H (1996) Treatment of small-cell lung carcinoma in the elderly. Cancer 77:2032–2038PubMedCrossRefGoogle Scholar
  17. Extermann M (2000) Measuring co-morbidity in older cancer patients. Eur J Cancer 36:453–471PubMedCrossRefGoogle Scholar
  18. Findlay MP, Griffin AM, Raghavan D, McDonald KE, Coates AS, Duval PJ, Gianoutsos P (1991) Retrospective review of chemotherapy for small-cell lung cancer in the elderly: Does the end justify the means? Eur J Cancer 27:1597–1601PubMedCrossRefGoogle Scholar
  19. Firat S, Pleister A, Wirad RW, Gore E (2006) Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of Stage III non-small-cell lung cancer (NSCLC). Am J Clin Oncol 29:252–257PubMedCrossRefGoogle Scholar
  20. Furuse K, Fukuoka M, Kawahara M, Nishikawa H, Takada Y, Kudoh S, Katagami N, Ariyoshi Y (1999) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable Stage III non-small-cell lung cancer. J Clin Oncol 17:2692–2699PubMedGoogle Scholar
  21. Gauden SJ, Tripcony L (2001) The curative treatment by radiation therapy alone of Stage I non-small-cell lung cancer in a geriatric population. Lung Cancer 32:71–79PubMedCrossRefGoogle Scholar
  22. Gauden S, Ramsay J, Tripcony L (1995) The curative treatment by radiotherapy alone of Stage I non-small cell carcinoma of the lung. Chest 108:1278–1282PubMedCrossRefGoogle Scholar
  23. Gava A (1999) Lung cancer radiation treatment in the elderly. Crit Rev Oncol Hematol 32:45–48PubMedCrossRefGoogle Scholar
  24. Ghosh S, Sujendran V, Alexiou C, Beggs L, Beggs D (2003) Long term results of surgery versus continuous hyper fractionated accelerated radiotherapy (CHART) in patients aged >70 years with Stage 1 non-small-cell lung cancer. Eur J Cardiothorac Surg 24:1002–1007PubMedCrossRefGoogle Scholar
  25. Giorgo CG, Pappalardo A, Ruso A (2007) A phase II induction chemotherapy followed by concurent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer. Anticancer Drugs 18:713–719CrossRefGoogle Scholar
  26. Haasbeek CJ, Lagerwaard FJ, Antonisse ME, Slotman BJ, Senan S (2010) Stage I non-small-cell lung cancer in patients aged > or =75 years: Outcomes after stereotactic radiotherapy. Cancer 116:406–414PubMedCrossRefGoogle Scholar
  27. Hanna N, Neubauer M, Yiannoutsos C, McGarry R, Arseneau J, Ansari R, Reynolds C, Govindan R, Melnyk A, Fisher W, Richards D, Bruetman D, Anderson T, Chowhan N, Nattam S, Mantravadi P, Johnson C, Breen T, White A, Einhorn L, Hoosier Oncology Group; US Oncology (2008) Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable Stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology. J Clin Oncol 26:5755–5760PubMedCrossRefGoogle Scholar
  28. Hayakawa K, Mitsuhashi N, Saito Y, Nakayama Y, Furuta M, Sakurai H, Kawashima M, Ohno T, Nasu S, Niibe H (1999) Limited field irradiation for medically inoperable patients with peripheral Stage I non-small-cell lung cancer. Lung Cancer 26:137–142PubMedCrossRefGoogle Scholar
  29. Hayakawa K, Mitsuhashi N, Katano S, Saito Y, Nakayama Y, Sakurai H, Akimoto T, Hasegawa M, Yamakawa M, Niibe H (2001) High-dose radiation therapy for elderly patients with inoperable or unresectable non-small-cell lung cancer. Lung Cancer 32:81–88PubMedCrossRefGoogle Scholar
  30. Hayman JA, Abrahamse PH, Lakhani I, Earle CC, Katz SJ (2007) Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 69:1001–1007PubMedCrossRefGoogle Scholar
  31. Higton AM, Monach J, Congleton J (2010) Investigation and management of lung cancer in older adults. Lung Cancer 69:209–212PubMedCrossRefGoogle Scholar
  32. Jara C, Gomez-Aldaravi JL, Tirado R, Meseguer VA, Alonso C, Fernandez A (1999) Small-cell lung cancer in the elderly: is age of patient a relevant factor? Acta-Oncol 38:781–786PubMedCrossRefGoogle Scholar
  33. Jatoi A, Schild SE, Foster N, Henning GT, Dornfeld KJ, Flynn PJ, Fitch TR, Dakhil SR, Rowland KM, Stella PJ, Soori GS, Adjei AA (2010) A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422). Ann Oncol 21:2040–2044PubMedCrossRefGoogle Scholar
  34. Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S (1997) Hyperfractionated radiotherapy alone for clinical Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 38:521–525PubMedCrossRefGoogle Scholar
  35. Jeremic B, Shibamoto Y, Milicic B, Nikolic N, Dagovic A, Milisavljevic S (1998a) Concurrent radiochemotherapy for patients with Stage III non-small-cell lung cancer (NSCLC): long-term results of a phase II study. Int J Radiat Oncol Biol Phys 42:1091–1096PubMedCrossRefGoogle Scholar
  36. Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S (1998b) Carboplatin, etoposide, and accelerated hyperfractionated radiotherapy for elderly patients with limited small-cell lung carcinoma: a phase II study. Cancer 82:836–841PubMedCrossRefGoogle Scholar
  37. Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S (1999a) Hyperfractionated radiotherapy for clinical Stage II non-small-cell lung cancer. Radiother Oncol 51:141–145PubMedCrossRefGoogle Scholar
  38. Jeremic B, Shibamoto Y, Milicic B, Milisavljevic S, Nikolic N, Dagovic A, Aleksandrovic J, Radosavljevic-Asic G (1999b) A phase II study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 44:343–348PubMedCrossRefGoogle Scholar
  39. Jeremic B, Shibamoto Y, Milicic B, Milisavljevic S, Nikolic N, Dagovic A, Aleksandrovic J, Radosavljevic-Asic G (1999c) Short-term chemotherapy and palliative radiotherapy for elderly patients with Stage IV non-small-cell lung cancer. A phase II study. Lung Cancer 24:1–9PubMedCrossRefGoogle Scholar
  40. Jeremic B, Shibamoto Y, Nikolic N, Milicic B, Milisavljevic S, Dagovic A, Aleksandrovic J, Radosavljevic-Asic G (1999d) Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: a randomized study. J Clin Oncol 17:2092–2099PubMedGoogle Scholar
  41. Joss RA, Bacchi M, Hurny C, Bernhard J, Cerny T, Martinelli G, Leyvraz S, Senn HJ, Stahel R, Siegenthaler P (1995) Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol 6:157–166PubMedGoogle Scholar
  42. Karasawa K, Niibe Y, Igaki H, Ieki R, Tanaka Y (2002) Radiotherapy combined with bronchial arterial infusion of CDDP in the treatment of Stage III non-small-cell lung cancer for aged patients. Int J Radiation Oncol Biol 54 (Suppl): 104 (Abstract 175)Google Scholar
  43. Kaskowitz L, Graham MV, Emami B, Halverson KJ, Rush C (1993) Radiation therapy alone for Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 27:517–523PubMedCrossRefGoogle Scholar
  44. Kelly P, O’Brien AA, Daly P, Clancy L (1991) Small-cell lung cancer in elderly patients: the case for chemotherapy. Age Ageing 20:19–22PubMedCrossRefGoogle Scholar
  45. Krol AD, Aussems P, Noordijk EM, Hermans J, Leer JW (1996) Local irradiation alone for peripheral Stage I lung cancer: Could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys 34:297–302PubMedCrossRefGoogle Scholar
  46. Kusumoto S, Koga K, Tsukino H, Nagamachi S, Nishikawa K, Watanabe K (1986) Comparison of survival of patients with lung cancer between elderly (greater than or equal to 70) and younger (70 greater than) age groups. Jpn J Clin Oncol 16:319–323PubMedGoogle Scholar
  47. Langer CJ, Scott CB, Byhardt RW (2000) Effect of advanced age on outcome in radiation therapy oncology group studies of locally advanced NSCLC. Lung Cancer 29:104 (Abstract 340)CrossRefGoogle Scholar
  48. Langer CJ, Hsu C, Curran WJ Jr et al (2001) Do elderly patients with locally advanced non-small-cell lung cancer benefit from combined modality therapy? A secondary analysis of RTOG 94–10. Int J Radiat Oncol Biol Phys 51(Suppl 23):31Google Scholar
  49. Livingston RB, Mira JG, Chen TT, McGowan M, Costanzi JJ, Samson M (1984) Combined modality treatment of extensive small-cell lung cancer: a Southwest Oncology Group study. J Clin Oncol 2:585–590PubMedGoogle Scholar
  50. Lonardi F, Coeli M, Pavanato G, Adami F, Gioga G, Campostrini F (2000) Radiotherapy for non-small-cell lung cancer in patients aged 75 and over: Safety, effectiveness and possible impact on survival. Lung Cancer 28:43–50PubMedCrossRefGoogle Scholar
  51. Ludbrok JJ, Truong PT, MacNeil MV, Lesperance M, Webber A, Joe H, Martins H, Lim J (2003) Do age and co-morbidity impact treatment allocation and outcomes in limited Stage small-cell lung cancer? A community-based population analysis. Int J Radiat Oncol Biol Phys 55:1321–1330CrossRefGoogle Scholar
  52. Matsui K, Masuda N, Fukuoka M, Yana T, Hirashima T, Komiya T, Kobayashi M, Kawahara M, Atagi S, Ogawara M, Negoro S, Kudoh S, Furuse K (1998) Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer. Br J Cancer 77:1961–1965PubMedCrossRefGoogle Scholar
  53. McKenna RJ Sr (1994) Clinical aspects of cancer in the elderly. Treatment decisions, treatment choices, and follow-up. Cancer 74:2107–2117PubMedCrossRefGoogle Scholar
  54. Monfardini S, Sorio R, Boes G, Kaye S, Serraino D (1995) Entry and evaluation of elderly patients in European Organization for research and Treatment of Cancer (EORTC) new-drug-development studies. Cancer 76:333–338PubMedCrossRefGoogle Scholar
  55. Montamat SC, Cusack BJ, Vestal RE (1989) Management of drug therapy in the elderly. N Engl J Med 321:303–309PubMedCrossRefGoogle Scholar
  56. Montella M, Gridelli C, Crispo A, Scognamiglio F, Ruffolo P, Gatani T, Boccia V, Maione P, Fabbrocini G (2002) Has lung cancer in the elderly different characteristics at presentation? Oncol Rep 9:1093–1096PubMedGoogle Scholar
  57. Morita K, Fuwa N, Suzuki Y, Nishio M, Sakai K, Tamaki Y, Niibe H, Chujo M, Wada S, Sugawara T, Kita M (1997) Radical radiotherapy for medically inoperable non-small-cell lung cancer in clinical Stage I: a retrospective analysis of 149 patients. Radiother Oncol 42:31–36PubMedCrossRefGoogle Scholar
  58. Movsas B, Scott C, Sause W, Byhardt R, Komaki R, Cox J, Johnson D, Lawton C, Dar AR, Wasserman T, Roach M, Lee JS, Andras E (1999) The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small-cell lung cancer (NSCLC): A quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies. Int J Radiat Oncol Biol Phys 45:1143–1149PubMedCrossRefGoogle Scholar
  59. Murray N, Grafton C, Shah A, Gelmon K, Kostashuk E, Brown E, Coppin C, Coldman A, Page R (1998) Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancer. J Clin Oncol 16:3323–3328PubMedGoogle Scholar
  60. Nakano K, Hiramoto T, Kanehara M, Doi M, Furonaka O, Miyazu Y, Hada Y (1999) Radiotherapy alone for elderly patients with Stage III non-small-cell lung cancer. Nihon Kokyki Gakkai Zasshi 37:276–281Google Scholar
  61. Nakano K, Yamamoto M, Iwamoto H, Hiramoto T (2003) Daily low-dose cisplatin plus concurrent high-dose thoracic radiotherapy in elderly patients with locally advanced unresectable non-small-cell lung cancer. Gan To Kagaku Ryoho 30:1283–1287PubMedGoogle Scholar
  62. Newaishy GA, Kerr GR (1989) Radical radiotherapy for bronchogenic carcinoma: five year survival rates. Clin Oncol (R Coll Radiol) 1:80–85CrossRefGoogle Scholar
  63. Niibe Y, Karasawa K, Shibuya M, Ieki R, Tanaka Y (2003) Prospective study of three-dimensional radiation therapy (3D-CRT) using a middle fraction size for small-sized lung tumor in elderly patients. Proc Am Soc Clin Oncol (Abstract 2702)Google Scholar
  64. Noguchi T, Mochizuki H, Yamazaki M, Kawate E, Suzuki Y, Sato T, Takahashi H (2010) A retrospective analysis of clinical outcomes of patients older than or equal to 80 years with small cell lung cancer. J Thorac Oncol 5:1081–1087PubMedGoogle Scholar
  65. Noordijk EM, vd Poest Clement E, Hermans J, Wever AM, Leer JW (1988) Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother Oncol 13:83–89PubMedCrossRefGoogle Scholar
  66. Nou E (1996) Full chemotherapy in elderly patients with small cell bronchial carcinoma. Acta-Oncol 35:399–406PubMedCrossRefGoogle Scholar
  67. Nugent WC, Edney MT, Hammerness PG, Dain BJ, Maurer LH, Rigas JR (1997) Non-small cell lung cancer at the extremes of age: Impact on diagnosis and treatment. Ann Thorac Surg 63:193–197PubMedCrossRefGoogle Scholar
  68. Okamoto K, Okamoto I, Takezawa K, Tachibana I, Fukuoka M, Nishimura Y, Nakagawa K (2010) Cisplatin and etoposide chemotherapy combined with early concurrent twice-daily thoracic radiotherapy for limited-disease small-cell lung cancer in elderly patients. Jpn J Clin Oncol 40:54–59PubMedCrossRefGoogle Scholar
  69. Osterlind K, Andersen PK (1986) Prognostic factors in small cell lung cancer: Multivariate model based on 778 patients treated with chemotherapy with or without irradiation. Cancer Res 46:4189–4194PubMedGoogle Scholar
  70. Osterweil D, Brummel-Smith K, Beck JC (eds) (2000) Comprehensive geriatric assessment. McGraw Hill, New YorkGoogle Scholar
  71. Owonikoko TK, Ragin CC, Belani CP, Oton AB, Gooding WE, Taioli E, Ramalingam SS (2007) Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol 25:5570–5577PubMedCrossRefGoogle Scholar
  72. Palma DA, Tyldesley S, Sheehan F, Mohamed IG, Smith S, Wai E, Murray N, Senan S (2010a) Stage I non-small cell lung cancer (NSCLC) in patients aged 75 years and older: Does age determine survival after radical treatment? J Thorac Oncol. 5:818–824PubMedCrossRefGoogle Scholar
  73. Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman BJ, Senan S (2010b) Impact of introducing stereotactic lung radiotherapy for elderly patients with Stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol 28:5153–5159PubMedCrossRefGoogle Scholar
  74. Park CH, Bonomi M, Cesaretti J, Neugut AI, Wisnivesky JP (2010) Effect of radiotherapy planning complexity on survival of elderly patients with unresected localized lung cancer. Int J Radiat Oncol Biol Phys. 2010 Oct 5. [Epub ahead of print]Google Scholar
  75. Patterson CJ, Hocking M, Bond M, Teale C (1998) Retrospective study of radiotherapy for lung cancer in patients aged 75 years and over. Age Ageing 27:515–518PubMedCrossRefGoogle Scholar
  76. Pergolizzi S, Santacaterina A, De Renzis C, Settineri N, Gaeta M, Frosina P, Russi EG, Altavilla G (2002) Older people with non small cell lung cancer in clinical Stage IIIA and co-morbid conditions. Is curative irradiation feasible? Final results of a prospective study. Lung Cancer 37:201–206PubMedCrossRefGoogle Scholar
  77. Pignon JP, Arriagada R, Ihde DC, Johnson DH, Perry MC, Souhami RL, Brodin O, Joss RA, Kies MS, Lebeau B (1992) A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327:1618–1624PubMedCrossRefGoogle Scholar
  78. Pignon T, Gregor A, Schaake-Koning C, Roussel A, Van Glabbeke M, Scalliet P (1998) Age has no impact on acute and late toxicity of curative thoracic radiotherapy. Radiother Oncol 46:239–248PubMedCrossRefGoogle Scholar
  79. Rocha Lima CM, Herndon JE, Kosty M, Clamon G, Green MR (2002) Therapy choices among older patients with ling carcinoma: an evaluation of two trials of the Cancer and Leukaemia Group B. Cancer 94:181–187PubMedCrossRefGoogle Scholar
  80. Rosenthal SA, Curran WJ Jr, Herbert SH, Hughes EN, Sandler HM, Stafford PM, McKenna WG (1992) Clinical Stage II non-small cell lung cancer treated with radiation therapy alone. The significance of clinically staged ipsilateral hilar adenopathy (N1 disease). Cancer 70:2410–2417PubMedCrossRefGoogle Scholar
  81. Rubenstein LZ (1995) An overview of comprehensive geriatric assessment: Rationale, history, program models, basic components. In: Rubinstein LZ, Wieland D, Bernabei R (eds) Geriatric assessment technology: the state of the art. Springer, New YorkGoogle Scholar
  82. Sagman U, Feld R, Evans WK, Warr D, Shepherd FA, Payne D, Pringle J, Yeoh J, DeBoer G, Malkin A (1991) The prognostic significance of pre-treatment serum lactate dehydrogenase in patients with small-cell lung cancer. J Clin Oncol 9:954–961PubMedGoogle Scholar
  83. San José S, Arnaiz MD, Lucas A, Navarro V, Serrano G, Zaderazjko M, Jeremic B, Guedea F (2005) Radiation therapy alone in elderly with early stage non-small-cell lung cancer. Lung Cancer 52:149–154CrossRefGoogle Scholar
  84. Sandler HM, Curran WJ Jr, Turrisi AT 3rd (1990) The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 19:9–13PubMedCrossRefGoogle Scholar
  85. Schaake-Koning C, van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, van Houtte P, Kirkpatrick A, Koolen M, Maat B, Nijs A (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326:524–530PubMedCrossRefGoogle Scholar
  86. Schild SE, Stella PJ, Geyer SM, Bonner JA, McGinnis WL, Mailliard JA, Brindle J, Jatoi A, Jett JR (2003) The outcome of combined-modality therapy for Stage III non-small-cell lung cancer in elderly. J Clin Oncol 21:3201–3206PubMedCrossRefGoogle Scholar
  87. Schild SE, Stella PJ, Brooks BJ, Mandrekar S, Bonner JA, McGinnis WL, Mailliard JA, Krook JE, Deming RL, Adjei AA, Jatoi A, Jett JR (2005) Results of combined-modality therapy for limited-stage small-cell lung carcinoma in the elderly. Cancer 103:2349–2354PubMedCrossRefGoogle Scholar
  88. Schild SE, Mandrekar SJ, Jatoi A, McGinnis WL, Stella PJ, Deming RL, Jett JR, Garces YI, Allen KL, Adjei AA, For the North Central Cancer Treatment Group (2007) The value of combined-modality therapy in elderly patients with Stage III non-small-cell lung cancer. Cancer 110:363–368PubMedCrossRefGoogle Scholar
  89. Semarau S, Klautke G, Wirchow JC, Kundt G, Fietkau R (2008) Impact of comorbidity and age on the outcome of patients with inoperable NSCLC treated with concurrent chemoradiotherapy. Respir Med 102:210–218CrossRefGoogle Scholar
  90. Sgroi MM, Neubauer M, Ansari R (2007) An analysis of elderly patients (pts) treated on a phase III trial of cisplatin plus etoposide (E) with concurrent radiotherapy (CRT) followed by docetaxel (D) vs observation in patients with Stage III non-small-cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 25: (Abstract 9037)Google Scholar
  91. Shepherd FA, Amdemichael E, Evans WK, Chalvardjian P, Hogg-Johnson S, Coates R, Paul K (1994) Treatment of small-cell lung cancer in the elderly. J Am Geriatr Soc 42:64–70PubMedGoogle Scholar
  92. Shimizu T, Sekine I, Sumi M, Ito Y, Yamada K, Nokihara H, Yamamoto N, Kunitoh H, Ohe Y, Tamura T (2007) Concurrent chemoradiotherapy for limited-disease small-cell lung cancer in elderly patients aged 75 years or older. Jpn J Clin Oncol 37:181–185PubMedCrossRefGoogle Scholar
  93. Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR (1998) Radiotherapy alone for medically inoperable Stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys 40:149–154PubMedCrossRefGoogle Scholar
  94. Siu LL, Shepherd FA, Murray N, Feld R, Pater J, Zee B (1996) Influence of age on the treatment of limited-stage small-cell lung cancer. J Clin Oncol 14:821–828PubMedGoogle Scholar
  95. Slotman BJ, Njo KH, Karim AB (1994) Curative radiotherapy for technically operable Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 29:33–37PubMedCrossRefGoogle Scholar
  96. Spiegelman D, Maurer LH, Ware JH, Perry MC, Chahinian AP, Comis R, Eaton W, Zimmer B, Green M (1989) Prognostic factors in small-cell carcinoma of the lung: an analysis of 1, 521 patients. J Clin Oncol 7:344–354PubMedGoogle Scholar
  97. Tebbutt NC, Snyder RD, Burns WI (1997) An analysis of the outcomes of treatment of small-cell lung cancer in the elderly. Aust N Z J Med 27:160–164PubMedCrossRefGoogle Scholar
  98. Tombolini V, Bonanni A, Donato V, Raffetto N, Santarelli M, Valeriani M, Enrici RM (2000) Radiotherapy alone in elderly patients with medically inoperable Stage IIIA and IIIB non-small-cell lung cancer. Anticancer Res 20:4829–4833PubMedGoogle Scholar
  99. Warde P, Payne D (1992) Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10:890–895PubMedGoogle Scholar
  100. Werner-Wasik M, Scott C, Cox JD, Sause WT, Byhardt RW, Asbell S, Russell A, Komaki R, Lee JS (2000) Recursive partitioning analysis of 1999 radiation therapy oncology group (RTOG) patients with locally advanced non-small-cell lung cancer (LA-NSCLC): Identification of five groups with different survival. Int J Radiat Oncol Biol Phys 48:1475–1482PubMedCrossRefGoogle Scholar
  101. Westeel V, Murray N, Gelmon K, Shah A, Sheehan F, McKenzie M, Wong F, Morris J, Grafton C, Tsang V, Goddard K, Murphy K, Parsons C, Amy R, Page R (1998) New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimen. J Clin Oncol 16:1940–1947PubMedGoogle Scholar
  102. Wisnivesky JP, Bonomi M, Henschke C, Iannuzzi M, McGinn T (2005) Radiation therapy for the treatment of unresected Stage I–II non-small-cell lung cancer. Chest 128:1461–1467PubMedCrossRefGoogle Scholar
  103. Wisnivesky JP, Halm E, Bonomi M, Powell C, Bagiella E (2010) Effectiveness of radiation therapy for elderly patients with unresected Stage I and II non-small-cell lung cancer. Am J Respir Crit Care Med 181:264–269PubMedCrossRefGoogle Scholar
  104. Wurschmidt F, Bunemann H, Bunemann C, Beck-Bornholdt HP, Heilmann HP (1994) Inoperable non-small-cell lung cancer: a retrospective analysis of 427 patients treated with high-dose radiotherapy. Int J Radiat Oncol Biol Phys 28:583–588PubMedCrossRefGoogle Scholar
  105. Yanick R (1997) Cancer burden in the aged: an epidemiologic and demographic overview. Cancer 80:1273–1283CrossRefGoogle Scholar
  106. Yu HM, Liu YF, Yu JM, Liu J, Zhao Y, Hou M (2008) Involved-field radiotherapy is effective for patients 70 years old or more with early stage non-small-cell lung cancer. Radiother Oncol 87:29–34PubMedCrossRefGoogle Scholar
  107. Yuen AR, Zou G, Turrisi AT, Sause W, Komaki R, Wagner H, Aisner SC, Livingston RB, Blum R, Johnson DH (2000) Similar outcome of elderly patients in intergroup trial 0096: Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small-cell lung carcinoma. Cancer 89:1953–1960PubMedCrossRefGoogle Scholar
  108. Zachariah B, Balducci L, Venkattaramanabalaji GV, Casey L, Greenberg HM, DelRegato JA (1997) Radiotherapy for cancer patients aged 80 and older: a study of effectiveness and side effects. Int J Radiat Oncol Biol Phys 39:1125–1129PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  1. 1.Institute of Lung DiseasesSremska KamenicaSerbia

Personalised recommendations